Prelude Therapeutics Incorporated (PRLD)
USD 0.91
(2.18%)
USD 0.91
(2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.16 Million | 3.04 Million | 2.24 Million | 542 Thousand | 382 Thousand | 149 Thousand |
| Gross Profit | -1.16 Million | -3.04 Million | -2.24 Million | -542 Thousand | -382 Thousand | -149 Thousand |
| Operating Expenses | 132.27 Million | 123.54 Million | 113.73 Million | 58.76 Million | 28.1 Million | 14.97 Million |
| Selling, General and Administrative Expenses | 28.88 Million | 30.65 Million | 26.95 Million | 10.58 Million | 3.83 Million | 2.35 Million |
| Research and Development Expenses | 103.39 Million | 92.88 Million | 86.77 Million | 48.17 Million | 24.27 Million | 12.62 Million |
| Other Expenses | - | 8.1 Million | 2.04 Million | 1.83 Million | 539 Thousand | 295 Thousand |
| Cost and Expenses | 132.27 Million | 123.54 Million | 113.73 Million | 58.76 Million | 28.1 Million | 14.97 Million |
| Operating Income | -132.27 Million | -123.54 Million | -113.73 Million | -58.76 Million | -28.1 Million | -14.97 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -8.1 Million | -915 Thousand | 335.7 Thousand | 210.14 Thousand | 295 Thousand |
| Earnings before Tax | -121.83 Million | -115.43 Million | -111.69 Million | -56.92 Million | -27.57 Million | -14.68 Million |
| Net Income | -121.83 Million | -107.33 Million | -110.77 Million | -56.92 Million | -27.57 Million | -14.68 Million |
| Earnings Per Share Basic | -2.02 | -2.27 | -2.33 | -1.30 | -0.85 | -0.46 |
| Earnings Per Share Diluted | -2.02 | -2.27 | -2.33 | -1.30 | -0.85 | -0.46 |
| Weighted Average Shares Outstanding | 60.35 Million | 47.37 Million | 47.6 Million | 43.7 Million | 32.4 Million | 32.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.35 Million | 47.37 Million | 47.6 Million | 43.7 Million | 32.4 Million | 32.1 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -131.1 Million | -122.21 Million | -112.82 Million | -58.22 Million | -27.72 Million | -14.82 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 3.42 Million | - | - | - |
| Cost of Revenue | 452 Thousand | 426 Thousand | 331 Thousand | 1.16 Million | 279 Thousand | 723 Thousand |
| Gross Profit | -452 Thousand | -426 Thousand | 3.09 Million | -1.16 Million | -279 Thousand | -723 Thousand |
| Operating Expenses | 36.71 Million | 34.34 Million | 37.37 Million | 131.1 Million | 33.38 Million | 32.39 Million |
| Selling, General and Administrative Expenses | 7.2 Million | 6.93 Million | 7.04 Million | - | 7.12 Million | 7.43 Million |
| Research and Development Expenses | 29.5 Million | 27.4 Million | 30.33 Million | - | 26.26 Million | 24.96 Million |
| Other Expenses | 2.42 Million | 2.91 Million | 4.3 Million | - | 2.77 Million | 1.96 Million |
| Cost and Expenses | 37.16 Million | 34.34 Million | 37.37 Million | 132.27 Million | 33.38 Million | 32.39 Million |
| Operating Income | -37.16 Million | -34.34 Million | -37.37 Million | -132.27 Million | -33.38 Million | -32.39 Million |
| Interest Expense | - | - | 1.39 Million | - | - | - |
| Income Tax Expense | - | -426 Thousand | 1.67 Million | -1.00 | -279 Thousand | 239.41 Thousand |
| Earnings before Tax | -34.74 Million | -31.43 Million | -33.07 Million | -121.83 Million | -30.6 Million | -30.43 Million |
| Net Income | -34.74 Million | -31.43 Million | -33.07 Million | -121.83 Million | -30.6 Million | -30.43 Million |
| Earnings Per Share Basic | -0.46 | -0.42 | -0.48 | - | -0.45 | -0.54 |
| Earnings Per Share Diluted | -0.46 | -0.42 | -0.48 | - | -0.45 | -0.54 |
| Weighted Average Shares Outstanding | 75.76 Million | 75.73 Million | 69.59 Million | 60.35 Million | 67.64 Million | 56.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.76 Million | 75.73 Million | 69.59 Million | 60.35 Million | 67.63 Million | 56.24 Million |
| Gross Margin | - | - | 0.90 | - | - | - |
| EBIT Margin | - | - | -10.82 | - | - | - |
| Profit Margin | - | - | -9.66 | - | - | - |
| EBITDA | -36.71 Million | -34.34 Million | -37.04 Million | - | -33.38 Million | -32.11 Million |
| Earnings Before Tax Margin | - | - | -10.92 | - | - | - |
DUOL
DOV
000582
GEECEE
JAGRAN
CRRX